Adi Yannai

Title: Adi Yannai: Innovator in Androgen-Dependent Disorder Treatments

Introduction

Adi Yannai is a notable inventor based in Haifa, Israel. She has made significant contributions to the field of medical treatments, particularly focusing on androgen-dependent disorders. Her innovative work has led to the development of a unique patent that addresses these health issues.

Latest Patents

Adi Yannai holds a patent for a composition and method for treating androgen-dependent disorders. The patent, titled "Composition and method for treating androgen-dependent disorders," involves chimeric polypeptides that include a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3α-HSD), fused to a signal peptide moiety. The invention also encompasses polynucleotides encoding the chimeric polypeptide and compositions that include at least one microorganism cell capable of secreting the chimeric polypeptide. This innovative approach provides methods and kits for treating, preventing, or ameliorating androgen-dependent disorders, including androgenic alopecia.

Career Highlights

Adi Yannai is associated with the Technion Research & Development Foundation Limited, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving health outcomes for individuals affected by androgen-dependent conditions.

Collaborations

Adi collaborates with talented individuals such as Roee Amit and Alexey Tomsov, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Adi Yannai's contributions to the treatment of androgen-dependent disorders highlight her role as a pioneering inventor in the medical field. Her innovative patent and collaborative efforts continue to pave the way for advancements in healthcare solutions.